| Quarterly Financials | Jun 2024 | Sept 2024 | Jun 2025 | Sept 2025 |
Revenue  | 6 | 3 | 3 | 10 |
| Expenses | 4 | 2 | 3 | 7 |
| EBITDA | 2 | 1 | 0 | 3 |
| Operating Profit % | 23 % | 23 % | 1 % | 27 % |
| Depreciation | 0 | 0 | 0 | 1 |
| Interest | 0 | 0 | 0 | 1 |
| Profit Before Tax | 1 | 1 | -0 | 2 |
| Tax | 0 | 0 | 0 | 1 |
| Net Profit | 1 | 0 | -0 | 1 |
| EPS in ₹ | 1.21 | 0.57 | -0.17 | 1.15 |
Auro Laboratories
Auro Laboratories
236.50
+0.70
(0.30%)
Market Cap
147.44 Cr
PE Ratio
79.93
Volume
525.00
Day High - Low
244.00 - 232.05
52W High-Low
317.00 - 159.00
Key Fundamentals
Market Cap
147.44 Cr
EPS
5.67
PE Ratio
79.93
PB Ratio
3.42
Book Value
74.36
EBITDA
12.00
Dividend Yield
0.00 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
7.62
Debt to Equity
1.21
Actual
Company News
View All News
Auro Laboratories reported a sharp turnaround in Q1FY26, with standalone revenue rising 178% YoY to ₹88.76 crore and net profit turning positive at ₹10.45 crore.
Auro Laboratories Limited will hold its 37th AGM on August 11, 2026, via video conferencing. The company has dispensed with physical copies of the annual report.
Auro Labs re-appoints Kiran Kulkarni for 3 years
Jun 30, 2026
Jun 30, 2026Auro Laboratories Ltd re-appoints Kiran Suresh Kulkarni as Whole Time Director for 3 years from May 24, 2027, subject to shareholder approval.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,902.40 | #1 4,56,449.48 | 37.64 | #1 61,673.90 | 12.69 | #1 11,565 | 26.53 | 43.08 | |
8,597.00 | 2,28,223.34 | 77.94 | 11,067.00 | 13.95 | 2,568 | 65.50 | 73.35 | |
4,896.50 | 1,86,247.12 | 88.12 | 13,886.20 | 20.34 | 2,138 | 3.28 | 48.73 | |
1,432.20 | 1,15,699.61 | 34.61 | 29,044.60 | 2.24 | 3,870 | -39.18 | 45.95 | |
1,120.00 | 1,12,698.21 | 24.08 | 27,657.90 | 17.64 | 5,026 | -34.90 | 48.15 | |
2,201.80 | 1,00,673.46 | #1 18.15 | 29,038.90 | #1 26.75 | 5,356 | 16.00 | 29.34 | |
2,384.00 | 98,458.24 | 47.64 | 14,636.40 | 14.85 | 1,938 | 29.13 | 39.76 | |
1,174.70 | 98,048.58 | 30.97 | 35,058.60 | 3.90 | 4,158 | -69.10 | 43.08 | |
1,802.00 | 97,282.16 | 90.34 | 6,867.80 | 22.01 | 890 | #1 123.93 | 60.02 | |
1,621.30 | 93,286.02 | 25.14 | 34,145.20 | 5.56 | 3,503 | 25.21 | 54.01 |
Growth Rate
Revenue Growth
62.69 %
Net Income Growth
94.44 %
Cash Flow Change
-57.97 %
ROE
78.04 %
ROCE
155.61 %
EBITDA Margin (Avg.)
81.27 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 29 | 26 | 27 | 30 | 34 | 32 | 42 | 55 | 56 | 86 | 99 | 121 |
| Fixed Assets | 10 | 9 | 13 | 13 | 15 | 14 | 14 | 14 | 13 | 22 | 21 | 75 |
| Current Assets | 18 | 12 | 14 | 16 | 19 | 18 | 28 | 38 | 36 | 31 | 21 | 31 |
| Capital Work in Progress | 1 | 3 | 0 | 1 | 0 | 0 | 0 | 4 | 8 | 33 | 57 | 15 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 18 | 13 | 14 | 16 | 19 | 18 | 28 | 38 | 36 | 31 | 22 | 31 |
| Total Equity & Liabilities | 29 | 26 | 27 | 30 | 34 | 32 | 42 | 55 | 56 | 86 | 99 | 121 |
| Current Liabilities | 14 | 10 | 6 | 7 | 7 | 6 | 9 | 20 | 18 | 24 | 22 | 29 |
| Non Current Liabilities | 8 | 7 | 11 | 11 | 10 | 5 | 4 | 3 | 4 | 20 | 35 | 46 |
| Total Equity | 8 | 9 | 9 | 13 | 17 | 22 | 29 | 32 | 34 | 42 | 43 | 46 |
| Reserve & Surplus | 2 | 2 | 3 | 7 | 11 | 15 | 22 | 25 | 28 | 36 | 37 | 40 |
| Share Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Net Cash Flow | -1 | 0 | 1 | 1 | 2 | 2 | 9 | -2 | -10 | -1 | -1 | 1 |
| Investing Activities | -1 | -2 | -2 | -3 | -3 | -2 | -4 | -5 | -5 | -39 | -24 | -15 |
| Operating Activities | -1 | 8 | 7 | 6 | 7 | 9 | 13 | -7 | 3 | 19 | 5 | 2 |
| Financing Activities | 1 | -5 | -4 | -2 | -2 | -6 | -1 | 10 | -8 | 19 | 18 | 14 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| Promoter | 51.92 % | 51.92 % | 51.93 % | 51.99 % | 51.99 % | 52.09 % | 52.09 % | 52.09 % | 52.09 % | 52.09 % | 52.09 % | 52.09 % | 52.15 % | 52.15 % | 52.15 % | 52.15 % | 52.18 % | 52.18 % | 52.18 % | 52.18 % | 52.18 % | 52.40 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 37.66 % | 36.94 % | 39.57 % | 39.57 % | 40.17 % | 40.12 % | 37.34 % | 39.82 % | 39.87 % | 37.58 % | 36.23 % | 35.56 % | 35.03 % | 35.33 % | 35.42 % | 36.15 % | 36.57 % | 36.42 % | 36.35 % | 36.26 % | 36.28 % | 36.56 % |
| Others | 10.41 % | 11.14 % | 8.50 % | 8.43 % | 7.83 % | 7.78 % | 10.57 % | 8.08 % | 8.03 % | 10.32 % | 11.68 % | 12.34 % | 12.81 % | 12.52 % | 12.43 % | 11.69 % | 11.25 % | 11.40 % | 11.47 % | 11.56 % | 11.54 % | 11.02 % |
| No of Share Holders | 9,151 | 9,377 | 10,129 | 10,189 | 11,340 | 11,362 | 11,183 | 11,135 | 10,906 | 10,501 | 10,272 | 9,905 | 9,441 | 9,335 | 9,266 | 9,265 | 9,102 | 8,916 | 8,860 | 8,640 | 8,405 | 8,315 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 28 Jun 2024 |  Annual General Meeting | NA | 28 Jun 2024 | 235.15 | 203.00 |
| 11 Nov 2024 |  Quarterly Result Announcement | NA | 11 Nov 2024 | 246.25 | 245.70 |
| 14 Feb 2025 | Quarterly Result Announcement | NA | 14 Feb 2025 | 230.35 | 224.80 |
| 30 May 2025 | Quarterly Result Announcement | NA | 30 May 2025 | 256.20 | 256.35 |
| 14 Aug 2025 | Quarterly Result Announcement | NA | 14 Aug 2025 | 268.45 | 258.00 |
| 25 Sept 2025 | Annual General Meeting | NA | 25 Sept 2025 | 247.35 | 240.60 |
| 12 Nov 2025 | Quarterly Result Announcement | NA | 12 Nov 2025 | 195.50 | 190.70 |
| 05 Feb 2026 | Quarterly Result Announcement | NA | 05 Feb 2026 | 207.20 | 253.95 |
| 29 May 2026 | Quarterly Result Announcement | NA | 29 May 2026 | 269.90 | 272.30 |
| 11 Aug 2026 | Annual General Meeting | NA | 11 Aug 2026 | 254.40 | 234.70 |
| 14 Aug 2026 | Quarterly Result Announcement | NA | 14 Aug 2026 | 234.75 | 240.10 |
Announcements
Announcement under Regulation 30 (LODR)-Newspaper Publication5 days ago
5 days ago Un-Audited Financial Results For The Quarter Ended June 30 2026.8 days ago
8 days agoBoard Meeting Outcome for Outcome Of Board Meeting Held On August 14 2026.8 days ago
8 days agoShareholder Meeting / Postal Ballot-Scrutinizers Report9 days ago
9 days agoShareholder Meeting / Postal Ballot-Outcome of AGMAug 11, 2026
Aug 11, 2026Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended June 30 2026.Aug 10, 2026
Aug 10, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 20, 2026
Jul 20, 2026 Regulation 36(1)(B) Of SEBI (LODR) Regulations 2015Jul 16, 2026
Jul 16, 2026Reg. 34 (1) Annual Report.Jul 16, 2026
Jul 16, 2026Notice Of 37Th Annual General Meeting (AGM) Scheduled On Tuesday August 11 2026Jul 16, 2026
Jul 16, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 15, 2026
Jul 15, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 15, 2026
Jul 15, 2026Announcement under Regulation 30 (LODR)-Change in ManagementJun 30, 2026
Jun 30, 2026Board Meeting Outcome for Outcome Of The Board Meeting Dated June 30 2026Jun 30, 2026
Jun 30, 2026Closure of Trading WindowJun 26, 2026
Jun 26, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 01, 2026
Jun 01, 2026Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 29, 2026
May 29, 2026Announcement under Regulation 30 (LODR)-Change in ManagementMay 29, 2026
May 29, 2026Results For The Year Ended March 31 2026May 29, 2026
May 29, 2026Board Meeting Outcome for Held On May 29 2026May 29, 2026
May 29, 2026Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)May 28, 2026
May 28, 2026Board Meeting Intimation for Board Meeting To Be Held On May 29 2026May 25, 2026
May 25, 2026Receipt Of Certification Of Substances Department From European Directorate For The Quality Of Medicines & Healthcare (EDQM)May 05, 2026
May 05, 2026Receipt Of Certificate Of GMP Compliance Of A Manufacturer From Swissmedic Swiss Agency For Therapeutic Products.May 05, 2026
May 05, 2026Announcement under Regulation 30 (LODR)-Credit RatingApr 14, 2026
Apr 14, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 14, 2026
Apr 14, 2026Closure of Trading WindowMar 26, 2026
Mar 26, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 07, 2026
Feb 07, 2026Financial Results For The Quarter Ended December 31 2025Feb 05, 2026
Feb 05, 2026Board Meeting Outcome for Outcome Of The Board MeetingFeb 05, 2026
Feb 05, 2026Board Meeting Intimation for Unaudited Financial Results For Quarter Ended December 31 2025.Jan 28, 2026
Jan 28, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 14, 2026
Jan 14, 2026Closure of Trading WindowDec 26, 2025
Dec 26, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 14, 2025
Nov 14, 2025Grant Of Certificate Of Good Manufacturing Practices From World Health Organisation (WHQ").Nov 12, 2025
Nov 12, 2025Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025Nov 12, 2025
Nov 12, 2025Board Meeting Outcome for Outcome Of The Board Meeting Dated November 12 2025Nov 12, 2025
Nov 12, 2025Board Meeting Intimation for Unaudited Financial Results Of The Company For Quarter And Half Year Ended September 30 2025.Nov 06, 2025
Nov 06, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 13, 2025
Oct 13, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 29, 2025
Sep 29, 2025Closure of Trading WindowSep 26, 2025
Sep 26, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 25, 2025
Sep 25, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 09, 2025
Sep 09, 2025 Regulation 36(1)(B) Of SEBI (LODR) RegulationsSep 03, 2025
Sep 03, 2025Reg. 34 (1) Annual Report.Sep 03, 2025
Sep 03, 2025Notice Of 36Th Annual General Meeting (AGM) Scheduled On Thursday September 25 2025Sep 03, 2025
Sep 03, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 02, 2025
Sep 02, 2025Appointment of Company Secretary and Compliance OfficerAug 23, 2025
Aug 23, 2025Board Meeting Outcome for Outcome Of Board Meeting Dated August 23 2025Aug 23, 2025
Aug 23, 2025Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sAug 23, 2025
Aug 23, 2025Technical Indicators
RSI(14)
Neutral 45.24
ATR(14)
Volatile 11.43
STOCH(9,6)
Neutral 28.18
STOCH RSI(14)
Neutral 49.57
MACD(12,26)
Bullish 0.37
ADX(14)
Weak Trend 18.94
UO(9)
Bearish 30.35
ROC(12)
Downtrend And Accelerating -1.03
WillR(14)
Neutral -66.35
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
